Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Omega Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 43 | +43 |
| Shares | 0 | 41.2M | +41.2M |
| Value | $0 | $772.9M | +$772.9M |
New holders (43)
Institutions that held Omega Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (0)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.